Another benefit is the dosing flexibility
Research examines convergent Gs / cAMP / PKA signalling across the three incretin receptors and downstream effects on energy expenditure pathways in animal models
Yet, while their ability to reduce body weight and insulin levels was greater than GLP1 monotherapy in male models 33,34,35 , the potential of these GLP1-based multi-agonists for the treatment of the metabolic, hormonal, and gonadal complications associated with PCOS has not been explored to date
The JAMA study, meanwhile, recorded a result of 16% over the same period
These elevations resolved without intervention in most cases
doi: 10.1111/dom.12291 225 ZhaoHWeiRWangLTianQTaoMKeJet al